MUHN HANS-PETER

No ORCID on file · 60 papers in corpus · active 1998-2012
2012

The disclosure relates to 8beta-substituted estra-1,3,5(10)-triene derivatives of general formula (I), wherein the variables are as defined in the specification, their use as pharmaceutical active ingredients, which have in vitro a higher a…

2012

The disclosure relates to 8beta-substituted estra-1,3,5(10)-triene derivatives of general formula (I), wherein the variables are as defined in the specification, their use as pharmaceutical active ingredients, which have in vitro a higher a…

2012

The disclosure relates to 8beta-substituted estra-1,3,5(10)-triene derivatives of general formula (I), wherein the variables are as defined in the specification, their use as pharmaceutical active ingredients, which have in vitro a higher a…

2012

The disclosure relates to 8beta-substituted estra-1,3,5(10)-triene derivatives of general formula (I), wherein the variables are as defined in the specification, their use as pharmaceutical active ingredients, which have in vitro a higher a…

2012

The disclosure relates to 8beta-substituted estra-1,3,5(10)-triene derivatives of general formula (I), wherein the variables are as defined in the specification, their use as pharmaceutical active ingredients, which have in vitro a higher a…

2012

The disclosure relates to 8beta-substituted estra-1,3,5(10)-triene derivatives of general formula (I), wherein the variables are as defined in the specification, their use as pharmaceutical active ingredients, which have in vitro a higher a…

2011

Pyridinone derivatives, process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially sex-hormone-rel…

2011

Pyridinone derivatives, process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially sex-hormone-rel…

2011

Pyridinone derivatives, process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially sex-hormone-rel…

2011

Pyridinone derivatives, process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially sex-hormone-rel…

2011

Pyridinone derivatives, process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially sex-hormone-rel…

2011

Pyridinone derivatives, process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially sex-hormone-rel…

2004

The nonsteroid gestagens can be used individually or in combination with estrogens in contraceptive preparations, in the treatment of endometriosis, as well as of gynaecological distrurbances. The compounds can find also application in the …

2004

The nonsteroid gestagens can be used individually or in combination with estrogens in contraceptive preparations, in the treatment of endometriosis, as well as of gynaecological distrurbances. The compounds can find also application in the …

2004

The nonsteroid gestagens can be used individually or in combination with estrogens in contraceptive preparations, in the treatment of endometriosis, as well as of gynaecological distrurbances. The compounds can find also application in the …

2004

The nonsteroid gestagens can be used individually or in combination with estrogens in contraceptive preparations, in the treatment of endometriosis, as well as of gynaecological distrurbances. The compounds can find also application in the …

2004

The nonsteroid gestagens can be used individually or in combination with estrogens in contraceptive preparations, in the treatment of endometriosis, as well as of gynaecological distrurbances. The compounds can find also application in the …

2004

The nonsteroid gestagens can be used individually or in combination with estrogens in contraceptive preparations, in the treatment of endometriosis, as well as of gynaecological distrurbances. The compounds can find also application in the …

2003

This invention describes the new, nonsteroidal gestagens of general formula Iin whichA, B, Ar1, R1, R2 and R3 have the meanings that are indicated in more detail in the description. The new compounds show a very great affinity to the gestag…

2003

This invention describes the new, nonsteroidal gestagens of general formula Iin whichA, B, Ar1, R1, R2 and R3 have the meanings that are indicated in more detail in the description. The new compounds show a very great affinity to the gestag…

2003

This invention describes the new, nonsteroidal gestagens of general formula I in which A, B, Ar, R, Rand Rhave the meanings that are, indicated in more detail in the description. The new compounds show a very great affinity to the gestagen …

2003

This invention describes the new, nonsteroidal gestagens of general formula I in which A, B, Ar, R, Rand Rhave the meanings that are, indicated in more detail in the description. The new compounds show a very great affinity to the gestagen …

2003

This invention describes the new, nonsteroidal gestagens of general formula Iin whichA, B, Ar1, R1, R2 and R3 have the meanings that are indicated in more detail in the description. The new compounds show a very great affinity to the gestag…

2003

This invention describes the new, nonsteroidal gestagens of general formula Iin whichA, B, Ar1, R1, R2 and R3 have the meanings that are indicated in more detail in the description. The new compounds show a very great affinity to the gestag…

2003

This invention describes the new, nonsteroidal gestagens of general formula I in which A, B, Ar, R, Rand Rhave the meanings that are, indicated in more detail in the description. The new compounds show a very great affinity to the gestagen …